Cite
MLA Citation
Aung Naing et al.. “Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial.” Lancet oncology, vol. 20, no. 11, 2019, pp. 1544–1555. http://access.bl.uk/ark:/81055/vdc_100094620722.0x000012